Rosacea Subtype 1 (Erythematotelangiectatic)
4 clinical trials · Condition
◉ Watch Rosacea Subtype 1 (Erythematotelangiectatic)
| Record | Firm | Date |
|---|---|---|
| Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy (NCT07521462) | ISISPHARMA | 2026-09-01 |
| Brimonidine 0.33% for Rosacea-Related Facial Erythema (NCT07431476) | Istanbul Training and Research Hospital | 2025-05-01 |
| Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial (NCT06776445) | First Affiliated Hospital of Chongqing Medical University | 2024-01-05 |
| Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic) (NCT01666509) | PBB Entrepreneur Ltd. | 2012-07-01 |
Track Rosacea Subtype 1 (Erythematotelangiectatic) automatically
Every clearance here is in the API, with alerts when new ones post.